11β-hydroxysteroid dehydrogenase type 1 inhibitors

被引：9

作者：

Boyle, Craig D. ^{[1
]}

Kowalski, Timothy J. ^{[1
]}

Zhang, Lili ^{[1
]}

机构：

[1] Schering Plough Res Inst, Kenilworth, NJ 07033 USA

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 41 | 2006年 / 41卷

关键词：

D O I：

10.1016/S0065-7743(06)41007-1

中图分类号：

R914 [药物化学];

学科分类号：

100701 [药物化学];

摘要：

[No abstract available]

引用

页码：127 / 140

页数：14

共 123 条

[1]

Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains [J].

Alberts, P ;

Nilsson, C ;

Selén, G ;

Engblom, LOM ;

Edling, NHM ;

Norling, S ;

Klingström, G ;

Larsson, C ;

Forsgren, M ;

Ashkzari, M ;

Nilsson, CE ;

Fiedler, M ;

Bergqvist, E ;

Öhman, B ;

Björkstrand, E ;

Abrahmsén, LB .

ENDOCRINOLOGY, 2003, 144 (11) :4755-4762

[2]

Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice [J].

Alberts, P ;

Engblom, L ;

Edling, N ;

Forsgren, M ;

Klingström, G ;

Larsson, C ;

Rönquist-Nii, Y ;

Öhman, B ;

Abrahmsén, L .

DIABETOLOGIA, 2002, 45 (11) :1528-1532

[3]

ALBISTON AL, 1994, MOL CELL ENDOCRINOL, V105, P11

[4]

AMREIN K, 2006, Patent No. 200600371

[5]

Amrein K., 2006, PCT Int Appl, Patent No. 2006010546

[6]

Andersen H.S., 2004, PCT Int. Appl, Patent No. 2004089367

[7]

Andersen H S., 2004, PCT 1nt. Appl, Patent No. 2004089380

[8]

Andersen H. S., 2004, World Patent, Patent No. [2004089470, Appl. WO 2004089470 A2]

[9]

Andersen H.S., 2004, Appl, Patent No. 2004089471

[10]

Effects of the 11β-hydroxysteroid dehydrogrenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes [J].

Andrews, RC ;

Rooyackers, O ;

Walker, BR .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) :285-291

← 1 2 3 4 5 6 7 8 9 10 →